Presenilins are part of a multi-protein γ-secretase enzyme complex, which mediates the γ-cleavage of amyloid precursor protein (APP) to produce Aβ peptides, a process which is dysregulated in Alzheimer’s disease [45]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.